Clariane (CLARI) AI Stock Analysis

• Market Cap: €1.86B
• Dividend Yield: N/A
• Average Volume (3M): 825.38K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.27
• Revenue Growth: 4.64%
• EPS Growth: 57.96%
• Country: FR
• Employees: 61,798
• Sector: Utilities
• Sector Strength: 67
• Industry: Medical - Care Facilities
• EPS (TTM): 0.04
• Shares Outstanding: 356,754,460
• 10 Day Avg. Volume: 1,020,614
• 30 Day Avg. Volume: 825,380
• PEG Ratio: -0.40
• Price to Book (P/B): 0.19
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 5.69
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €2.70
• Price Target Upside: -48.28% Downside
• Rating Consensus: Moderate Sell
• Number of Analyst Covering: 1

• Rating: 66 Neutral
• Price Target: €5.50 ▲(5.36%Upside)

Korian SA's strong technical indicators and operational efficiencies are notable strengths. However, the negative valuation metrics and profitability challenges significantly impact the overall score.

Clariane Business Overview & Revenue Model

Company Description

Korian SA (CLARI) is a leading European provider of long-term care and assisted living services, primarily catering to the elderly. The company operates a network of care facilities, including nursing homes, post-acute and rehabilitation clinics, and assisted living facilities. Korian is committed to enhancing the quality of life for senior citizens through personalized care solutions across several European countries.

How the Company Makes Money

Korian SA generates its revenue primarily through the operation of its extensive network of care facilities. The company charges fees for the various services provided at its nursing homes, rehabilitation clinics, and assisted living facilities. These fees are typically paid by residents, their families, or through government and insurance programs. Korian's earnings are significantly influenced by occupancy rates, service pricing, and its ability to manage operational costs effectively. Additionally, the company may benefit from partnerships with healthcare providers and suppliers to enhance service offerings and optimize resource utilization.

Clariane Financial Statement Overview

Summary

Korian SA showcases strong operational efficiencies and cash flow management, underpinned by consistent revenue growth. However, the company faces profitability challenges and potential risks associated with high leverage.

Income Statement

Korian SA has shown consistent revenue growth with a compound annual growth rate over the past five years. Despite recent net losses, the company maintains healthy gross and EBIT margins, indicating operational efficiency. The net profit margin remains negative due to the net losses, which impacts overall profitability.

Balance Sheet

The company's balance sheet reflects a high debt-to-equity ratio, suggesting significant leverage, which could pose risks if not managed properly. However, the equity ratio is stable, indicating a sound asset base. Return on equity has been under pressure due to recent net losses, which affects investor returns.

Cash Flow

Korian SA has demonstrated strong cash flow generation capabilities, with rising operating cash flow and positive free cash flow growth. The operating cash flow to net income ratio is robust, highlighting efficient cash flow management. However, the free cash flow to net income ratio is impacted by the net losses.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	5.28B	5.00B	4.44B	4.14B	3.77B
Gross Profit	4.84B	1.57B	4.09B	3.83B	3.48B
EBITDA	1.01B	907.48M	907.45M	841.76M	760.02M
Net Income	-55.12M	-105.25M	22.06M	91.11M	39.40M
Balance Sheet
Total Assets	14.26B	15.18B	14.57B	14.31B	13.20B
Cash, Cash Equivalents and Short-Term Investments	518.10M	677.91M	734.35M	1.22B	1.16B
Total Debt	7.98B	8.55B	8.27B	8.23B	7.71B
Total Liabilities	10.24B	11.24B	10.71B	10.54B	9.87B
Stockholders Equity	3.69B	3.58B	3.54B	3.49B	3.16B
Cash Flow
Free Cash Flow	600.10M	309.05M	116.36M	311.05M	274.67M
Operating Cash Flow	908.13M	804.15M	681.66M	839.97M	794.77M
Investing Cash Flow	47.69M	-669.52M	-770.26M	-825.28M	-1.10B
Financing Cash Flow	-1.11B	-193.61M	-370.09M	31.38M	1.11B

Clariane Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 5.22
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:CLARI, the sentiment is Positive. The current price of 5.22 is above the 20-day moving average (MA) of 4.79, above the 50-day MA of 4.22, and above the 200-day MA of 2.96, indicating a bullish trend. The MACD of 0.34 indicates Negative momentum. The RSI at 66.13 is Neutral, neither overbought nor oversold. The STOCH value of 77.03 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FR:CLARI.

Clariane Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CLARI	66 Neutral	€1.86B	―	-0.83%	―	4.64%	57.96%
Sector *	62 Neutral	€6.89B	3.78	-1.70%	4.51%	9.31%	-12.31%
LNA	60 Neutral	€268.84M	12.09	7.12%	2.52%	9.58%	-6.69%
LNA	60 Neutral	€268.84M	12.09	7.12%	2.52%	9.58%	-6.69%
GDS	49 Neutral	€1.22B	―	-6.74%	―	5.79%	-575.58%
GDS	49 Neutral	€1.22B	―	-6.74%	―	5.79%	-575.58%
EMEIS	48 Neutral	€1.90B	0.02	-22.82%	―	8.43%	-102.06%
EMEIS	48 Neutral	€1.90B	0.02	-22.82%	―	8.43%	-102.06%